Solicitation 75N98026Q01123.pdf
PDF 188 KB Posted
- Attached to
- Vivo Efficacy of Blood stable Thiobenzamides
- Solicitation number
- 75N98026Q01123
About this file
This is a Combined Synopsis/Solicitation for a firm-fixed-price commercial services contract issued by the National Institutes of Health (NIH), Office of the Director, Office of Acquisitions. The solicitation number is 75N98026Q01123 for "Vivo Efficacy of Blood stable Thiobenzamides," and the contract value is not expected to exceed $350,000.00 (simplified acquisition threshold). The associated NAICS code is 325414 with a small business size standard of 1,000 employees. This requirement is NOT set-aside for small businesses.
The Government requires services across three categories: (1) Mouse and Disease Model—mouse model development, disease induction, and treatment for 20 samples; (2) Monitoring and Readouts—viral load monitoring (BSL-3), sample collection, immunophenotyping on blood, and immunophenotyping following ex vivo stimulation for 20 samples each; and (3) Project Management and Reporting—project management with updates and one standard report. Responses must include unit and total price, shipping and handling costs, delivery timeframe after award, delivery terms, F.O.B. point (destination), product/service description, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov. Award will be made to the contractor providing the most advantageous quote, with technical factors outweighing cost, and may consider past performance and total evaluated price. All responses must be received by September 20, 2026, at 9:00am EST and may be submitted electronically to danielt@mail.nih.gov with reference to solicitation number 75N98026Q01123.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
COMBINED SYNOPSIS / SOLICITATION
Solicitation No.: 75N98026Q01123
Title: Vivo Efficacy of Blood stable Thiobenzamides
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350,000.00.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026.
The associated NAICS code is 325414, and the small business size standard is 1,000 employees.
This requirement is NOT SET-ASIDE for SMALL BUSINESSES
Description of Requirement:
The Government requires the following.
SERVICE DESCRIPTION
MOUSE AND DISEASE MODEL
Mouse model, disease induction, and treatment 20 each
MONITORING AND READOUTS
Viral load monitoring (BSL-3) 20 each Sample collection 20 each Immunophenotyping on blood 20 each Immunophenotyping following ex vivo stimulation 20 each
PROJECT MANAGEMENT AND REPORTING
Project management and updates 1 each Standard report 1 each
PROVISIONS AND CLAUSES
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Products and Commercial Services, applies to this acquisition.
The provision at FAR 52.212-2, Instructions to Offerors—Commercial Products and Commercial Services, applies to this acquisition.
The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered.
EVALUATION CRITERIA:
Award will be made to the contractor providing the most advantageous quote to the government, technical factors and cost/price considered.
Factors outweigh cost.
The Government may consider, as applicable:
• Past performance; and
• Total evaluated price.
A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date.
Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services, with their offer.
FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services, applies to this acquisition.
FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders, applies to this acquisition.
Submission Requirements:
Responses must include sufficient information to demonstrate the offeror’s capability to provide the required product or service. Quotes shall include, at a minimum:
• Unit and total price
• Shipping and handling costs
• Delivery timeframe after award
• Delivery terms
• F.O.B. point (destination)
• Product or catalog numbers (if applicable)
• Product/service description
Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.
Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.
All responses must be received by September 20, 2026, at 9:00am EST and must reference solicitation number 75N98026Q01123.
Responses may be submitted electronically to danielt@mail.nih.gov.
http://www.sam.gov/
File details come from the government source that posted it. Updated .